Q&A: Why are children most affected by this year's cold and flu season?
The 2023 flu season is shaping up to be like the influenza season of 2019—the largest on record in Australia.
Jul 19, 2023
0
1
The 2023 flu season is shaping up to be like the influenza season of 2019—the largest on record in Australia.
Jul 19, 2023
0
1
Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year.
Jul 18, 2023
0
7
As a result of the COVID-19 pandemic, respiratory syncytial virus (RSV) surges in young children occurred outside the usual November to March season, when immune-based prophylactic is available to protect children at high ...
Jul 14, 2023
0
18
After pandemic restrictions eased, cases of respiratory infections surged worldwide. There were record numbers of people infected with respiratory syncytial virus (RSV), flu and even strep A.
Jul 14, 2023
0
1
Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses. By combining recent advances in aerosol sampling technology and an ultrasensitive ...
Jul 10, 2023
0
126
Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention has announced.
Jul 3, 2023
0
47
Each omicron wave so far in Australia has had distinguishing features—the sharp rise and fall of BA.1, the widespread transmission among children and families in BA.2, a shift to more infections in older people with BA.5, ...
Jun 13, 2023
0
2
A U.S. Food and Drug Administration advisory panel on Thursday recommended that the agency approve an RSV vaccine for infants and some toddlers.
Jun 9, 2023
0
2
The European Commission has followed the United States in approving the world's first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday.
Jun 7, 2023
0
2
The US drug regulator approved a second vaccine against respiratory syncytial virus (RSV), its American developer Pfizer said Wednesday, a month after the authorization of the first shot against the pathogen, a leading cause ...
Jun 1, 2023
0
2